Latest Diabetes: Type II news
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
posted March 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
posted February 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Weight-Loss Surgery Produces Lasting Diabetes Remission .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Related Articles
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Monthly Specialist Briefings
Stay Connected
